Improving HIV treatment and monitoring in South Africa
Simplifying HIV Treatment and Monitoring (STREAM2): Point-of-Care Urine Tenofovir Adherence and Viral Load Testing to Improve HIV Outcomes in South Africa
This study is looking at a new way to help people with HIV stick to their treatment by using quick urine tests to check how well the medicine is working and if patients are taking it as they should, so they can get immediate feedback and support for better health.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-10895299 on NIH RePORTER |
What this research studies
This research focuses on enhancing the management of HIV treatment by implementing point-of-care testing for both viral load and adherence to medication using urine samples. By utilizing innovative testing methods, the study aims to provide immediate feedback to patients and healthcare providers, thereby improving adherence to antiretroviral therapy (ART) and ensuring better health outcomes. The research builds on previous findings that showed increased viral suppression when using point-of-care monitoring, and it seeks to evaluate the effectiveness of these methods in real-world settings.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living with HIV who are receiving antiretroviral therapy in South Africa.
Not a fit: Patients who are not currently receiving HIV treatment or those who are not located in South Africa may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved health outcomes for people living with HIV by ensuring better adherence to treatment and more effective monitoring of viral load.
How similar studies have performed: Previous studies have shown success with point-of-care monitoring approaches, indicating a promising avenue for improving HIV treatment outcomes.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Drain, Paul K — University of Washington
- Study coordinator: Drain, Paul K
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.